These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27203389)

  • 1. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
    Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
    Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tumor growth by circulating full-length chromogranin A.
    Curnis F; Dallatomasina A; Bianco M; Gasparri A; Sacchi A; Colombo B; Fiocchi M; Perani L; Venturini M; Tacchetti C; Sen S; Borges R; Dondossola E; Esposito A; Mahata SK; Corti A
    Oncotarget; 2016 Nov; 7(45):72716-72732. PubMed ID: 27683038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study.
    Bachetti T; Ferrari Bardile A; Aloi TL; Colombo B; Assi E; Savino G; Vercelli A; Colombo R; Corti A
    Int J Cardiol; 2017 Jun; 236():438-443. PubMed ID: 28190616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
    Corsello A; Di Filippo L; Massironi S; Sileo F; Dolcetta Capuzzo A; Gemma M; Carlucci C; Cusini C; Colombo B; Dallatomasina A; Franchi GM; Corti A; Manzoni MF
    PLoS One; 2018; 13(5):e0196858. PubMed ID: 29723285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
    Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
    Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin-A production and fragmentation in patients with Takayasu arteritis.
    Tombetti E; Colombo B; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bozzolo EP; Tombolini E; Benedetti G; Godi C; Lanzani C; Rovere-Querini P; Del Maschio A; Ambrosi A; De Cobelli F; Sabbadini MG; Baldissera E; Corti A; Manfredi AA
    Arthritis Res Ther; 2016 Aug; 18():187. PubMed ID: 27531191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HS1 has a central role in the trafficking and homing of leukemic B cells.
    Scielzo C; Bertilaccio MT; Simonetti G; Dagklis A; ten Hacken E; Fazi C; Muzio M; Caiolfa V; Kitamura D; Restuccia U; Bachi A; Rocchi M; Ponzoni M; Ghia P; Caligaris-Cappio F
    Blood; 2010 Nov; 116(18):3537-46. PubMed ID: 20530793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
    Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
    Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
    Mahata SK; Corti A
    Ann N Y Acad Sci; 2019 Nov; 1455(1):34-58. PubMed ID: 31588572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Chromogranin A and Its Fragments in Biological Fluids.
    Curnis F; Colombo B; Corti A
    Methods Mol Biol; 2023; 2565():343-359. PubMed ID: 36205905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogranin A (CGA)-derived polypeptide (CGA
    Luo L; Liu S; Zhang D; Wei F; Gu N; Zeng Y; Chen X; Xu S; Liu S; Xiang T
    Peptides; 2020 Sep; 131():170297. PubMed ID: 32380199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients.
    Bianco M; Gasparri AM; Colombo B; Curnis F; Girlanda S; Ponzoni M; Bertilaccio MT; Calcinotto A; Sacchi A; Ferrero E; Ferrarini M; Chesi M; Bergsagel PL; Bellone M; Tonon G; Ciceri F; Marcatti M; Caligaris-Cappio F; Corti A
    Cancer Res; 2016 Apr; 76(7):1781-91. PubMed ID: 26869462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromogranin A and the endothelial barrier function.
    Corti A; Ferrero E
    Curr Med Chem; 2012; 19(24):4051-8. PubMed ID: 22834794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
    Bailón E; Ugarte-Berzal E; Amigo-Jiménez I; Van den Steen P; Opdenakker G; García-Marco JA; García-Pardo A
    J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration.
    Belloni D; Scabini S; Foglieni C; Veschini L; Giazzon A; Colombo B; Fulgenzi A; Helle KB; Ferrero ME; Corti A; Ferrero E
    FASEB J; 2007 Oct; 21(12):3052-62. PubMed ID: 17566084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxation induced by N-terminal fragments of chromogranin A in mouse gastric preparations.
    Amato A; Serio R; Mulè F
    Regul Pept; 2007 Mar; 139(1-3):90-5. PubMed ID: 17126925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
    Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
    Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.
    Blois A; Srebro B; Mandalà M; Corti A; Helle KB; Serck-Hanssen G
    Regul Pept; 2006 Jul; 135(1-2):78-84. PubMed ID: 16725215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.
    Kress CL; Konopleva M; Martínez-García V; Krajewska M; Lefebvre S; Hyer ML; McQueen T; Andreeff M; Reed JC; Zapata JM
    PLoS One; 2007 Jun; 2(6):e559. PubMed ID: 17593960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma.
    Reni M; Andreasi V; Gasparri AM; Dugnani E; Colombo B; Macchini M; Bianco M; Dallatomasina A; Citro A; Assi E; Protti MP; Esposito A; Falconi M; Curnis F; Piemonti L; Corti A
    Front Oncol; 2020; 10():613582. PubMed ID: 33425767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.